HIGHLIGHTS
- who: Antiestrogens and collaborators from the Department of Molecular Pathology, National Institute of Oncology, Budapest, Hungary University of Bari Aldo Moro, Italy have published the research work: Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens, in the Journal: (JOURNAL)
- what: The developing new trends in anticancer fight are targeting mutated genes by gene therapy and attacking their altered protein products by immunotherapy.
SUMMARY
Tamoxifen as a first line therapy induced moderate tumor regression rate ( and amp;lt;40%-50%) even among the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.